Related references
Note: Only part of the references are listed.U-100, pH-Neutral formulation of VIAject®: faster onset of action than insulin lispro in patients with type 1 diabetes
L. Heinemann et al.
DIABETES OBESITY & METABOLISM (2012)
Insulin analogues and cancer risk: the emergence of second-generation studies
A. G. Renehan
DIABETOLOGIA (2012)
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
R. Ruiter et al.
DIABETOLOGIA (2012)
Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
P. Blin et al.
DIABETOLOGIA (2012)
Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials
Faramarz Ismail-Beigi et al.
ANNALS OF INTERNAL MEDICINE (2011)
Closed-loop insulin delivery for treatment of type 1 diabetes
Daniela Elleri et al.
BMC MEDICINE (2011)
Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps
P. Schaepelynck et al.
DIABETES & METABOLISM (2011)
A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naive People With Type 2 Diabetes A randomized, controlled trial
Tim Heise et al.
DIABETES CARE (2011)
Insulin Degludec in Type 1 Diabetes A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine
Kare I. Birkeland et al.
DIABETES CARE (2011)
Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology
Elsemiek E. C. Engwerda et al.
DIABETES CARE (2011)
Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis
A. E. Pontiroli et al.
DIABETES OBESITY & METABOLISM (2011)
Intradermal Microneedle Delivery of Insulin Lispro Achieves Faster Insulin Absorption and Insulin Action than Subcutaneous Injection
Ronald J. Pettis et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Long-term effects of insulin glargine on the risk of breast cancer
S. Suissa et al.
DIABETOLOGIA (2011)
USE OF RECOMBINANT HUMAN HYALURONIDASE TO ACCELERATE RAPID INSULIN ANALOGUE ABSORPTION: EXPERIENCE WITH SUBCUTANEOUS INJECTION AND CONTINUOUS INFUSION
Daniel E. Vaughn et al.
ENDOCRINE PRACTICE (2011)
Glargine Promotes Proliferation of Breast Adenocarcinoma Cell Line MCF-7 via AKT Activation
J. -A. Teng et al.
HORMONE AND METABOLIC RESEARCH (2011)
Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial
Bernard Zinman et al.
LANCET (2011)
Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Bioresponsive matrices in drug delivery
Jin-Oh You et al.
Journal of Biological Engineering (2011)
Conformational Dynamics of Insulin
Qing-Xin Hua et al.
Frontiers in Endocrinology (2011)
Long-Acting Insulin Analogs: A Review of Real-World Effectiveness in Patients with Type 2 Diabetes
Richard F. Pollock et al.
CURRENT DIABETES REVIEWS (2011)
Risk of cancer in patients receiving insulin glargine
Leslie K. Dawson et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2010)
Effects of Intensive Glucose Lowering in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
Matthew C. Riddle
CIRCULATION (2010)
RAPID-ACTING INSULIN ANALOGUES IN BASAL-BOLUS REGIMENS IN TYPE 1 DIABETES MELLITUS
Satish Garg et al.
ENDOCRINE PRACTICE (2010)
An Achilles' Heel in an Amyloidogenic Protein and Its Repair INSULIN FIBRILLATION AND THERAPEUTIC DESIGN
Yanwu Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Supramolecular Protein Engineering DESIGN OF ZINC-STAPLED INSULIN HEXAMERS AS A LONG ACTING DEPOT
Nelson B. Phillips et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Virus assembly occurs following a pH- or Ca2+-triggered switch in the thermodynamic attraction between structural protein capsomeres
Yap P. Chuan et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2010)
Optimal Control of Blood Glucose: The Diabetic Patient or the Machine?
Larry Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Insulin Glargine and NPH Insulin Increase to a Similar Degree Epithelial Cell Proliferation and Aberrant Crypt Foci Formation in Colons of Diabetic Mice
Jutta M. Nagel et al.
Hormones & Cancer (2010)
Insulin Glulisine: An Evaluation of Its Pharmacodynamic Properties and Clinical Application
Kristen L. Helms et al.
ANNALS OF PHARMACOTHERAPY (2009)
Cost-effectiveness of insulin analogues for diabetes mellitus
Chris G. Cameron et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Effect of a Local Heating Device on Insulin and Glucose Pharmacokinetic Profiles in an Open-Label, Randomized, Two-Period, One-Way Crossover Study in Patients With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Itamar Raz et al.
CLINICAL THERAPEUTICS (2009)
Insulin Glargine: a review 8 years after its introduction
Stanislav Goykhman et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes
Mike A. Baxter
ACTA DIABETOLOGICA (2008)
Is the use of insulin analogues cost-effective?
Steven Leichter
ADVANCES IN THERAPY (2008)
The allosteric role of the Ca2+ switch in adhesion and elasticity of C-cadherin
Marcos Sotomayor et al.
BIOPHYSICAL JOURNAL (2008)
UV cross-linked dextran methacrylate - Concanavalin a methacrylamide gel materials for self-regulated insulin delivery
M. Joan Taylor et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2008)
Design of an active ultrastable single-chain insulin analog - Synthesis, structure, and therapeutic implications
Qing-Xin Hua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The structure of a mutant insulin uncouples receptor binding from protein allostery - An electrostatic block to the TR transition
Zhu-li Wan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein therapeutics: A summary and pharmacological classification
Benjamin Leader et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms
Deborah G. Conrady et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Metallo-supramolecular modules as a paradigm for materials science
Dirk G. Kurth
SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2008)
History of protein crystallography in China
Zihe Rao
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2007)
pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity
Wayne D. Kohn et al.
PEPTIDES (2007)
Novel insulin analogues and its mitogenic potential
Ivana Zib et al.
DIABETES OBESITY & METABOLISM (2006)
Insulin aspart: a review
David Owens et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
DM Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Basal Bolus Dosing: A Clinical Experience
Allen B. King et al.
CURRENT DIABETES REVIEWS (2005)
Drug therapy: Insulin analogues
IB Hirsch
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin
S Havelund et al.
PHARMACEUTICAL RESEARCH (2004)
Crystallographic and solution studies of N-lithocholyl insulin:: A new generation of prolonged-acting human insulins
JL Whittingham et al.
BIOCHEMISTRY (2004)
Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness
RP Radermecker et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2004)
Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis
J Colquitt et al.
DIABETIC MEDICINE (2003)
Systematic characterization of the zinc-finger-containing proteins in the mouse transcriptome
T Ravasi et al.
GENOME RESEARCH (2003)
Pathogenesis of type 1 and type 2 diabetes mellitus in sub-Saharan Africa: implications for transitional populations
K Osei et al.
JOURNAL OF CARDIOVASCULAR RISK (2003)
New perspectives into the molecular pathogenesis and treatment of Type 2 diabetes
AR Saltiel
CELL (2001)
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo
L Heinemann et al.
DIABETES CARE (2000)
Share Paper
